Sun et al. [91] demonstrated that quiescin sulfhydryl oxidase 1 (QSOX1) inhibited NRF2 activation during sorafenib-induced ferroptosis in HCC cells. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.